If you liked this article you might like

Allergan, Citigroup, Apple: Doug Kass' Views
4 Biotech Names That Could Be M&A Targets
3 Biotechs Screaming 'Takeover Target'
17 Thoughts on Biotech Stocks to Kick Off 2017